Prospective Clinical Validation of the InVisionFirst-Lung Circulating Tumor DNA Assay for Molecular Profiling of Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer

PURPOSE: Guidelines advocate molecular profiling in the evaluation of advanced non–small-cell lung cancer (NSCLC) and support the use of plasma circulating tumor DNA (ctDNA)-based profiling for patients with insufficient tissue. Thorough prospective clinical validation studies of next-generation seq...

Descripción completa

Detalles Bibliográficos
Autores principales: Pritchett, Michael A., Camidge, D. Ross, Patel, Manu, Khatri, Jamil, Boniol, Steven, Friedman, Elke K., Khomani, Abderrahim, Dalia, Samir, Baker-Neblett, Katherine, Plagnol, Vincent, Howarth, Karen D., Jones, Gregory R., Rosenfeld, Nitzan, Morris, Clive D., Govindan, Ramaswamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450945/
https://www.ncbi.nlm.nih.gov/pubmed/32914040
http://dx.doi.org/10.1200/PO.18.00299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450945/
https://www.ncbi.nlm.nih.gov/pubmed/32914040
http://dx.doi.org/10.1200/PO.18.00299

Ejemplares similares